Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Elisabeth Bermudez"'
Autor:
François Lemare, Florian Slimano, Maxime Annereau, Elisabeth Bermudez, Romain-Pacôme Desmaris
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 27(7)
Objective The development of oncology day-hospital activities contributes to increase quality of life of patients and consequently have changed their perception about waiting. The extemporaneous preparation of antineoplastic has become difficult to a
Autor:
Hélène, Denis, Claire, Davoine, Elisabeth, Bermudez, Ghislain, Grosjean, Manon, Schwager, Norbert, Ifrah, Muriel, Dahan, Sophie, Negellen
Publikováno v:
Bulletin du cancer. 106(1)
The offer of anti-cancer drugs has recently been disrupted by the introduction of checkpoint inhibitors on the market. Currently, one anti-CTLA-4, two anti-PD-1 and two anti-PD-L1 are authorized in the European Union, in seven different types of canc
Autor:
Marie-Lucie Brunet, G. Firtion, C. Guerin, P.-H. Jarreau, Elisabeth Bermudez, F. Chast, N. Abbas, Camille Imbert
Publikováno v:
Le Pharmacien Hospitalier et Clinicien. 50:413-421
Resume Introduction A ce jour, seul l’azidothymidine (AZT ou Retrovir ® ) possede l’AMM dans l’indication « prevention de la transmission materno-fœtale du VIH ». Cependant, certaines molecules antiretrovirales a formulation pediatrique com
Autor:
François Lemare, Sébastien Klein, Lionel Tortolano, Elisabeth Bermudez, Florian Slimano, Romain Desmaris, Claire Hamel
Publikováno v:
Pediatric bloodcancer. 65(4)
BACKGROUND Systematic prescription analyses by clinical pharmacists result in pharmacist interventions (PIs) to reduce prescription errors and improve medication safety. PIs are particularly critical in oncology, because antineoplastic drugs are high
Autor:
Quentin Dardonville, Elisabeth Bermudez, Ghislain Grosjean, Sophie Negellen, Muriel Dahan, Claire Davoine, Norbert Ifrah
Publikováno v:
Journal of Clinical Oncology. 36:e15031-e15031
e15031Background: The launch of CAR-T cells raises major issues in terms of therapeutic strategies, safety, organization of care, financial sustainability. Regarding these challenges and the strong...
Autor:
Cédric Chanat, Pierre-Henri Jarreau, Elisabeth Bermudez, F. Chast, Marie-Lucie Brunet, Clément Delage
Publikováno v:
Le Pharmacien Hospitalier et Clinicien. 49:311
Introduction Le Pediaven® AP–HP nouveau-ne 2 (PNN2) est une solution de nutrition parenterale indiquee chez le nouveau-ne, premature ou non. Sa composition est adaptee a leurs besoins specifiques. En neonatologie, l’interet majeur du PNN2 repose
Publikováno v:
Le Pharmacien Hospitalier et Clinicien. 49:333
Introduction Jusqu’en 2013, les infirmieres du service de reanimation neonatale preparaient les seringues de melanges vitamino-lipidiques (MVL) sous une hotte a flux d’air laminaire. Une etude menee en 2011 ayant montre la faisabilite de la stand
Autor:
Hélène Denis, Marianne Duperray, Krol Aurélie, Sophie Negellen, Norbert Ifrah, Thierry Breton, Elisabeth Bermudez
Publikováno v:
Journal of Clinical Oncology. 38(15_suppl):e14134-e14134
e14134 Background: The European joint action iPAAC, funded by the European Commission, aims to develop innovative approaches to advances in cancer control. The field of anticancer drugs has strongly evolved over the past years and the clinical develo